Article Figures & Data
Figures
- Fig 1.
Study flow diagram.
- Fig 2.
Receiver operator characteristic curves of PET for differentiating recurrent glioma from treatment-induced necrosis (18F-fluorodeoxyglucose PET for both high- and low-grade glioma histology [A], and high-grade glioma only [B], and 11C-methionine PET for high-grade glioma only [C]). The size of each circle is proportional to the sample size of the corresponding study (all study participants). The dashed line represents the 95% confidence region for the summary sensitivity and specificity (depicted by a square).
In this issue
Jump to section
Related Articles
Cited By...
- Distinguishing Progression from Pseudoprogression in Glioblastoma Using 18F-Fluciclovine PET
- Amino Acid PET in Neurooncology
- Amino Acid PET in Neurooncology
- Diagnostic value of PET with different radiotracers and MRI for recurrent glioma: a Bayesian network meta-analysis
- Positron emission tomography and perfusion weighted imaging in the detection of brain tumors recurrence: A meta-analysis
- 11C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
- Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature
- Response Assessment in Neuro-Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques
- Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and 11C-Methionine PET/CT for Differentiation of Tumor Recurrence from Radiation Injury in Patients with High-Grade Gliomas
- Positron emission tomography (PET) for prediction of glioma histology: protocol for an individual-level data meta-analysis of test performance
- Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis
- Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study
- Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging
- A Meta-Analysis on the Diagnostic Performance of 18F-FDG and 11C-Methionine PET for Differentiating Brain Tumors
- Prediction of Pseudoprogression in Patients with Glioblastomas Using the Initial and Final Area Under the Curves Ratio Derived from Dynamic Contrast-Enhanced T1-Weighted Perfusion MR Imaging